Italian Digital Clinic Holifya Raises EUR2M for AI-Supported Obesity Care

Holifya, an Italian digital clinic, has secured EUR2 million in investment to expand its AI-supported pharmacologic treatment for obesity. The clinic leverages artificial intelligence and advanced diagnostics to provide comprehensive care. This investment round included €1.6 million in equity.

This successful raise for Italian obesity digital clinic Holifya raises €2M to scale AI-supported GLP-1 care highlights a growing European trend toward integrating AI and sophisticated diagnostic tools into digital health solutions for chronic conditions. Obesity represents a significant public health challenge across Europe, affecting over 436 million people. It is associated with a 50% higher risk of cardiovascular disease (CVD) mortality, contributing to an economic burden exceeding EUR210 billion annually.

European initiatives are actively exploring AI's role in addressing obesity and related health challenges. The AI-POD project, for example, is developing trustworthy AI tools to predict obesity-related vascular diseases, aiming to improve individual risk assessment for major adverse CVD events. Current risk scores are often insufficient, and AI-POD seeks to integrate more accurate predictions into user-friendly solutions.

Similarly, the HealthyW8 project aims to advance obesity prevention initiatives across Europe. It focuses on empowering healthy lifestyle behaviors through personalised intervention portfolios, adapting to individual contexts. HealthyW8 incorporates pre-obesity biomarkers and mHealth technologies to provide digital empowerment and health literacy. These projects collectively underscore the increasing focus on AI-driven solutions to improve risk prediction, personalise prevention, and enhance treatment efficacy for obesity.

What this means: The successful funding round for Holifya, alongside ongoing European research projects, signals a strong market and research commitment to AI-driven digital health solutions for chronic conditions like obesity. This trend is set to enhance personalised care and improve health outcomes across Europe by making advanced diagnostics and tailored treatments more accessible.